Should I buy Agilent Technologies (A) stock or is it too late?
⭐ The most reliable of them, either direction: Morgan Stanley — 69% of its targets hit on this sector (825 calls tested). It aims for $175 (+11 %), call made on August 13, 2026, maturing on August 13, 2027 (15 d ago).
Firm-by-firm track record on Agilent Technologies
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Wells Fargo | 75 % | +21.5 % | 16 | $160 +1% |
| Goldman Sachs | 78 % | +18.1 % | 9 | $170 +8% |
| Baird | 59 % | +12.3 % | 22 | $156 -1% |
| Evercore ISI Group | 60 % | +11.6 % | 5 | $148 -6% |
| Barclays | 67 % | +10.6 % | 18 | $150 -5% |
| Morgan Stanley | 86 % | +10.4 % | 14 | $175 +11% |
| JP Morgan | 67 % | +10.3 % | 12 | $180 +14% |
| Citigroup | 64 % | +9.7 % | 11 | $185 +17% |
✅ Reasons to believe
- 82% of analysts rate it a buy (Buy consensus, 11 ratings) — a sign of market conviction.
- The most reliable firm on A, Morgan Stanley (86% hit rate, 14 scored calls), targets $175 (call made on August 12, 2026, maturing on August 12, 2027) (+11%) in its most recent call, and $180 (call made on December 2, 2025, maturing on December 2, 2026) (+14%) in the one coming due soonest.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 11 ratings, 2 are neutral.
- Limited upside: the median target is only -2% from the current price.
- High valuation (P/E ~31): strong growth is already "priced in", leaving little room for error.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on A
Median target $155 (-2%) · 11 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Agilent Technologies now?
We won't decide for you. The facts: 82% of analysts rate it a buy, median target $155 (-2%), and Morgan Stanley (most reliable on A, 86%) targets $175. Weigh that against valuation (P/E ~31). This is not personalized advice.
Is it too late to invest in Agilent Technologies?
The stated upside is small: the median target ($155) sits just -2% from the price ($158) (most reliable on A: Morgan Stanley, 86%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Agilent Technologies still worth investing in?
It depends on the gap between the price ($158) and its estimated value: analysts target $155 on median (-2%), with 82% buys (most reliable on A: Morgan Stanley, 86%). Cross-check with their real reliability on A and the cautions above. Information, not advice.
What's the main risk in buying A?
The consensus is not unanimous: of 11 ratings, 2 are neutral.
→ Go deeper: the full Agilent Technologies profile (consensus, analyst reliability, price target, performance).